⌘K

Login Start Free

Home/Filings/4/0001127602-25-003232

4//SEC Filing

FARRELL PETER C 4

Accession 0001127602-25-003232

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:49 PM ET

Size

4.6 KB

Accession

0001127602-25-003232

Insider Transaction Report

Form 4

Period: 2025-02-05

FARRELL PETER C

Director

Transactions

Sale
ResMed Common Stock
2025-02-05$242.11/sh−2,000$484,220→ 77,218 total

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001186102

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 4:49 PM ET
Size: 4.6 KB

View on SEC.gov